We are live on ! Find out more
KALA icon

KALA BIO
KALA

28 hedge funds and large institutions have $12.8M invested in KALA BIO in 2022 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 8 increasing their positions, 6 reducing their positions, and 31 closing their positions.

New
Increased
Maintained
Reduced
Closed

843% more capital invested

Capital invested by funds: $1.36M → $12.8M (+$11.5M)

33% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 6

0.44% more ownership

Funds ownership: 0% → 0.44% (+0.44%)

47% less funds holding

Funds holding: 53 → 28 (-25)

81% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 31

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $2.38M

Holders
28
Holders Change
-25
Holders Change %
-47.17%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
8
Reduced
6
Closed
31
Calls
–
Puts
$2.38M
Net Calls
-$2.38M
Net Calls Change
-$2.38M

Top Buyers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
+$608K
2
Millennium Management
Millennium Management
New York
+$511K
3
CS
Clear Street
New York
+$391K
4
Jane Street
Jane Street
New York
+$205K
5
Bank of America
Bank of America
North Carolina
+$105K

Top Sellers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
-$107K
2
VAFP
Vahanian & Associates Financial Planning
New York
-$46K
3
Citadel Advisors
Citadel Advisors
Florida
-$30K
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$20K
5
Northern Trust
Northern Trust
Illinois
-$18K
Name Holding Trade Value Shares
Change 		Change in
Stake
SPIA
26
Steward Partners Investment Advisory
New York
$4.58K – – –
TRCT
27
Tower Research Capital (TRC)
New York
$3K -$5.54K -14 -88%
Wells Fargo
28
Wells Fargo
California
$2.63K -$396 -1 -50%
WAM
29
Worth Asset Management
Texas
$382 – – –
PA
30
Parallel Advisors
California
$38 – – –
VAFP
31
Vahanian & Associates Financial Planning
New York
– -$46K -83 Closed
Citadel Advisors
32
Citadel Advisors
Florida
– -$30K -53 Closed
T. Rowe Price Associates
33
T. Rowe Price Associates
Maryland
– -$20K -36 Closed
Northern Trust
34
Northern Trust
Illinois
– -$18K -33 Closed
VF
35
Virtu Financial
New York
– -$14K -26 Closed
OC
36
Oppenheimer & Co
New York
– -$13K -25 Closed
Two Sigma Investments
37
Two Sigma Investments
New York
– -$11K -21 Closed
Man Group
38
Man Group
United Kingdom
– -$10K -18 Closed
GWM
39
Greenwich Wealth Management
Connecticut
– -$7K -12 Closed
Simplex Trading
40
Simplex Trading
Illinois
– -$6K -12 Closed
Qube Research & Technologies (QRT)
41
Qube Research & Technologies (QRT)
United Kingdom
– -$6K -11 Closed
Bank of New York Mellon
42
Bank of New York Mellon
New York
– -$4K -8 Closed
CAG
43
Csenge Advisory Group
Florida
– -$4K -8 Closed
Fidelity Investments
44
Fidelity Investments
Massachusetts
– -$4K -8 Closed
GWM
45
GSB Wealth Management
Connecticut
– -$4K -8 Closed
WS
46
Wedbush Securities
California
– -$4K -8 Closed
SFI
47
Susquehanna Fundamental Investments
Pennsylvania
– -$4K -7 Closed
Creative Planning
48
Creative Planning
Kansas
– -$3K -6 Closed
HF
49
HRT Financial
New York
– -$3K -6 Closed
IIA
50
IPG Investment Advisors
California
– -$3.17K -6 Closed
1
2
3

KALA Hedge Fund Activity: Q4 2022 in Review

28 of the 6,222 institutional investors tracked by Wall St. Rank reported a position in KALA BIO (KALA) for Q4 2022, worth a combined $12.8M — up 843% from $1.36M a quarter earlier.

Sellers outnumbered buyers: 31 funds closed out of KALA and 6 opened new positions — a net loss of 25 holders — while 6 trimmed existing stakes and 8 added.

The largest buyer was Baker Bros. Advisors, opening a new position worth an estimated $608K. The largest seller was Vanguard Group, cutting an estimated $107K.

  • 28 institutional investors held KALA BIO (KALA) as of Q4 2022, down from 53 in Q3 2022.
  • Funds reported $12.8M of KALA BIO stock for Q4 2022, up 843% quarter-over-quarter.
  • 6 funds opened new KALA BIO positions in Q4 2022 and 31 closed out, a net change of -25 holders.
  • The largest KALA BIO buyer in Q4 2022 was Baker Bros. Advisors, an estimated $608K added.
  • The largest KALA BIO seller in Q4 2022 was Vanguard Group, an estimated $107K sold.

Based on aggregated 13F filings for Q4 2022.